ByHeart, which launched in 2021, is recalling batches of its “Whole Nutrition Infant Formula” because some of the product may ...

Abbott Laboratories (NYSE:ABT) is included among the 15 Best Dividend Growth Stocks to Buy Now. On October 24, Citi a‌nalyst ...

The fate of hundreds of pending cases against Abbott and Mead Johnson hang in the balance with the latest dismissal.

The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm ...

Saying trial lawyers have not yet shown evidence of an alternative to cow's milk-based infant formula that would not leave ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The current price target for ABT is $142.55, which after ...

Abbott Laboratories backed its full-year outlook after posting higher sales in the third quarter, boosted by sales of its nutrition shakes and drinks for adults. The healthcare-products maker on ...

Abbott Laboratories (NYSE:ABT) is one of the stocks in Jim Cramer’s game plan for this week. Cramer called the stock “terrific,” as he said: “We also get results from one of the most reliable ...

WASHINGTON AP - State officials say drugmaker Abbott Laboratories will pay $22.5 million to settle allegations that it tried to block generic competition to a popular cholesterol medication.The ...

Abbott Labs is a well-established medical device giant with a robust, diversified business. The healthcare giant has an incredible innovative streak that has allowed it to remain a leader. Abbott is ...